| 2024年中报 | 2023年年报 | 2023年中报 | 2022年年报 | 2022年中报 | |
|---|---|---|---|---|---|
| 营业收入(元) | |||||
| 禽流感疫苗(元) | 45,050,165.18 | 101,102,177.60 | 45,841,821.63 | 104,428,887.43 | 49,005,225.05 |
| 猪瘟系列疫苗(元) | 61,963,412.50 | 190,458,047.53 | 95,271,076.33 | 229,382,419.59 | 97,643,081.13 |
| 技术转让(元) | 7,382,132.87 | 10,234,465.39 | 6,626,622.77 | 5,979,671.92 | 4,906,809.03 |
| 其他疫苗(元) | 4,780,462.89 | 12,488,170.96 | 4,975,200.16 | 8,926,576.90 | 3,953,329.62 |
| 营业成本(元) | |||||
| 禽流感疫苗(元) | 32,744,457.96 | 83,187,334.46 | 35,020,819.40 | 78,618,026.68 | 33,782,165.94 |
| 猪瘟系列疫苗(元) | 13,233,388.92 | 38,695,360.39 | 19,632,011.91 | 45,254,800.23 | 18,371,498.88 |
| 技术转让(元) | - | - | - | - | - |
| 其他疫苗(元) | 3,255,809.18 | 7,525,152.80 | 3,207,092.11 | 6,787,817.76 | 2,785,209.30 |
| 毛利(元) | |||||
| 禽流感疫苗(元) | 12,305,707.22 | 17,914,843.14 | 10,821,002.23 | 25,810,860.75 | 15,223,059.11 |
| 猪瘟系列疫苗(元) | 48,730,023.58 | 151,762,687.14 | 75,639,064.42 | 184,127,619.36 | 79,271,582.25 |
| 技术转让(元) | 7,382,132.87 | 10,234,465.39 | - | - | - |
| 其他疫苗(元) | 1,524,653.71 | 4,963,018.16 | 1,768,108.05 | 2,138,759.14 | 1,168,120.32 |
| 毛利率(%) | |||||
| 禽流感疫苗(%) | 27.32 | 17.72 | 23.61 | 24.72 | 31.06 |
| 猪瘟系列疫苗(%) | 78.64 | 79.68 | 79.39 | 80.27 | 81.19 |
| 技术转让(%) | - | - | - | - | - |
| 其他疫苗(%) | 31.89 | 39.74 | 35.54 | 23.96 | 29.55 |
| 收入构成(%) | |||||
| 禽流感疫苗(%) | 37.80 | 32.17 | 30.02 | 29.95 | 31.51 |
| 猪瘟系列疫苗(%) | 51.99 | 60.60 | 62.38 | 65.78 | 62.79 |
| 技术转让(%) | 6.19 | 3.26 | 4.34 | 1.71 | 3.16 |
| 其他疫苗(%) | 4.01 | 3.97 | 3.26 | 2.56 | 2.54 |
| 毛利构成(%) | |||||
| 禽流感疫苗(%) | 17.59 | 9.69 | 12.26 | 12.17 | 15.91 |
| 猪瘟系列疫苗(%) | 69.67 | 82.09 | 85.73 | 86.82 | 82.87 |
| 技术转让(%) | 10.55 | 5.54 | 0.00 | 0.00 | 0.00 |
| 其他疫苗(%) | 2.18 | 2.68 | 2.00 | 1.01 | 1.22 |